Announcements in Conjunction With Theratechnologies Annual Meeting
(firmenpresse) - MONTREAL, CANADA -- (Marketwired) -- 05/24/13 -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Paul Pommier, chairman of the board of Theratechnologies.
At the meeting, the following people were elected as company directors by a majority of the votes.
At the meeting, the shareholder rights plan was renewed, and KPMG was appointed as auditors of the Corporation.
Appointment of new chairman
Immediately after the meeting, the board members met to appoint Dawn Svoronos as the new chair of the board, as previously announced.
They also confirmed Luc Tanguay as president and CEO of Theratechnologies.
About Theratechnologies
Theratechnologies (TSX: TH) is a biopharmaceutical company that specializes in innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at , on SEDAR at and on the Securities and Exchange Commission website at .
Contacts:
Denis Boucher
NATIONAL Public Relations
514-843-2393
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.05.2013 - 17:04 Uhr
Sprache: Deutsch
News-ID 263363
Anzahl Zeichen: 2499
contact information:
Town:
MONTREAL, CANADA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 292 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Announcements in Conjunction With Theratechnologies Annual Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von
Theratechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
